Handelsbanken Fonder’s Aurinia Pharmaceuticals AUPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$872K Buy
51,400
+4,200
+9% +$67.1K ﹤0.01% 1196
2026
Q1
$700K Hold
47,200
﹤0.01% 1193
2025
Q4
$753K Hold
47,200
﹤0.01% 1170
2025
Q3
$522K Hold
47,200
﹤0.01% 1244
2025
Q2
$400K Sell
47,200
-13,500
-22% -$108K ﹤0.01% 1336
2025
Q1
$488K Hold
60,700
﹤0.01% 1246
2024
Q4
$545K Hold
60,700
﹤0.01% 1252
2024
Q3
$445K Buy
60,700
+7,100
+13% +$44K ﹤0.01% 1297
2024
Q2
$306K Buy
53,600
+20,100
+60% +$106K ﹤0.01% 1381
2024
Q1
$168K Buy
33,500
+1,900
+6% +$12.9K ﹤0.01% 1530
2023
Q4
$284K Hold
31,600
﹤0.01% 1396
2023
Q3
$246K Hold
31,600
﹤0.01% 1377
2023
Q2
$306K Sell
31,600
-3,800
-11% -$39.4K ﹤0.01% 1333
2023
Q1
$388K Hold
35,400
﹤0.01% 1135
2022
Q4
$153K Buy
35,400
+9,900
+39% +$57.4K ﹤0.01% 1474
2022
Q3
$192K Hold
25,500
﹤0.01% 1445
2022
Q2
$256K Hold
25,500
﹤0.01% 1410
2022
Q1
$316K Hold
25,500
﹤0.01% 1490
2021
Q4
$583K Buy
+25,500
New +$604K ﹤0.01% 1247

Other funds holding AUPH

Handelsbanken Fonder's AUPH Position: Q2 2026 in Review

Handelsbanken Fonder increased its Aurinia Pharmaceuticals (AUPH) stake by 8.9% in Q2 2026, buying an estimated $67.1K and bringing the position to 51,400 shares worth $872K. The position accounts for ﹤0.01% of the portfolio, ranked #1196.

Handelsbanken Fonder first reported a position in AUPH in Q4 2021 and has held it in 19 quarters since. 64 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • Handelsbanken Fonder held 51,400 shares of Aurinia Pharmaceuticals worth $872K as of Q2 2026.
  • Handelsbanken Fonder bought 4,200 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $67.1K.
  • Aurinia Pharmaceuticals made up ﹤0.01% of Handelsbanken Fonder's portfolio in Q2 2026, its #1196 holding.
  • Handelsbanken Fonder first reported a position in Aurinia Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
  • 64 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.